May 18, 2018

Join Drs.

February 19, 2018

Written in plain terms and organized for quick review, the popular Family Planning: A Global Handbook for Providers offers clinic-based health care professionals in low- and middle-income countries the latest guidance on providing contraceptive methods. Updated to include expanded contra

July 25, 2017

To mark the 9th IAS Conference on HIV Science, the Lancet journals have made a selection of content free that reflects some of the breadth and diversity of clinical, epidemiological, and operational HIV research produced by the tireless global HIV community.

June 26, 2017

Topical prevention of HIV and other STIs is a global health priority. To provide options for users, developers have worked to design safe, effective and acceptable vaginal dissolving film formulations.

June 19, 2017

Women globally need access to multipurpose prevention technologies (MPTs) that prevent human immunodeficiency virus (HIV), sexually transmitted infections that increase HIV acquisition/transmission risk, and unintended pregnancy.

December 6, 2016

For persons at risk of HIV infection who practice receptive anal intercourse (RAI), topical rectal microbicides represent a promising option for coitally-dependent protection.

December 5, 2016

Antiretroviral medications that are used as prophylaxis can prevent acquisition of human immunodeficiency virus type 1 (HIV-1) infection. However, in clinical trials among African women, the incidence of HIV-1 infection was not reduced, probably because of low adherence.

November 30, 2016

Under the Preventive Technologies Agreement supported by the US Agency for International Development, FHI 360 implemented two projects designed to increase understanding of the gender issues likely to affect women’s microbicide use.

November 16, 2016

The Pathways to High Adherence manual was designed for research teams that are involved in supporting adherence to use of antiretroviral-based vaginal rings in HIV prevention clinical trials.

October 23, 2016

A number of presentations at the 2016 HIV Research for Prevention Conference (HIVR4P) in Chicago looked at the influence vaginal bacteria have on HIV susceptibility, and one presentation found that vaginal bacteria may have profound effects on the